Good adherence to HIV treatment, undetectable viral load, reduce the risk of anal infection with high-risk HPV types for MSM with HIV
Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk
Anal cancer screening may be appropriate for all women with HIV, French researchers suggest
HIV-positive young women have adequate response to human papillomavirus vaccine
Liver cancer often diagnosed late with poor survival in people with HIV
HPV type 39 linked to anal dysplasia, better screening needed for HIV+ men and women
